期刊文献+

生产禽流感病毒的悬浮MDCK细胞稳定性的研究 被引量:4

Stability of Suspended MDCK Cells for Avian Influenza Virus Production
下载PDF
导出
摘要 旨为研究悬浮MDCK细胞在长期传代过程中细胞生长稳定性与病毒生产稳定性。以悬浮MDCK细胞为研究对象,通过对该细胞进行了长达200多天的传代培养,考察了传代过程中各代次细胞的生长情况以及对H9N2禽流感病毒的生产能力差异;探究了不同培养基稀释比例和MOI等工艺参数条件对长期传代的悬浮MDCK细胞生产H9N2禽流感病毒过程的影响关系;另外,从ROS水平和细胞周期两方面,研究了高低代次细胞的病毒生产能力差异的内在原因。结果显示,各代次悬浮MDCK细胞形态相似,细胞生长能力无显著性差异,表明该细胞在长期传代过程中细胞生长稳定性良好。但HA滴度随细胞代次的增加而增加,最高代次细胞(P111)的病毒滴度较最低代次细胞(P1)约高0.5 Log2HAU/100μL;P111细胞在不同工艺下病毒产量均高于P1细胞,表明了该细胞长期传代后病毒生产能力略有提高。最后,研究发现,与P1相比,P111胞内ROS水平较低并且G0/G1期细胞的比例较高,此现象可能是高代次细胞产量提高的原因。 The aim of this study is to determine the stability of growing and virus producing for suspension MDCK cells during long-term passaging culture.Suspended MDCK cells were subcultured for more than 200 d.Taking suspended MDCK cells at different passaging time points,their growth patterns and the difference in virus production of H9N2 avian influenza virus(H9N2-AIV)were investigated.The effects of different process parameters and conditions such as medium dilution ratios and MOI on the production of H9N2-AIV from the suspended long-term passaging MDCK cells was explored.The reasons for the difference in H9N2-AIV production capacity between the lowest passaged cells(P1)and the highest passaged cells(P111)were preliminarily investigated from two aspects,i.e.the intracellular ROS level and cell cycle.The results showed that the MDCK cells at the different passages presented similar morphology,and insignificant difference was observed concerning cell growth between all subcultures and batch cultures,which indicated that the growth of the MDCK cells were stable during longterm passaging.The HA titer increased with elevated cell passaging time,the HA titer of P111 was about 0.5 Log2HAU/100μL higher than that of P1.Meanwhile,P111 cells produced higher virus than P1 cells under different tested processes,indicating that the H9N2-AIV production capacity of the suspended MDCK cells had slightly increased with the increase of cell passaging time.It was also found that P111 cells had lower ROS level and higher proportion of G0/G1-phase cells,which may be the main reasons for the increased yield of H9N2-AIV from MDCK cells.
作者 白春丽 叶倩 姬阿美 刘旭平 张旭 刘志亮 朱明龙 赵亮 谭文松 BAI Chun-li;YE Qian;JI A-mei;LIU Xu-ping;ZHANG Xu;LIU Zhi-liang;ZHU Ming-long;ZHAO Liang;TAN Wen-song(State Key Laboratory of Bioreactor Engineering,East China University of Science and Technology,Shanghai 200237;Shanghai Bioengine Biotechnology Co.Ltd.,Shanghai 201203;Shandong Sinder Animal Vaccine Co.Ltd.,Weifang 262204)
出处 《生物技术通报》 CAS CSCD 北大核心 2020年第10期72-79,共8页 Biotechnology Bulletin
基金 国家自然科学基金项目(21878083) 动物疫苗智能制造新模式应用项目(YB2018-XMS)。
关键词 悬浮MDCK细胞 禽流感病毒 细胞株稳定性 ROS 细胞周期 suspended MDCK cells avian influenza virus cell line stability ROS cell cycle
  • 相关文献

参考文献9

二级参考文献38

  • 1郭潮潭,陈勇.流感病毒的受体结构与跨越物种传播的分子机制[J].国外医学(流行病学.传染病学分册),2005,32(2):80-83. 被引量:8
  • 2王秋林,王浩毅,王树人.氧化应激状态的评价[J].中国病理生理杂志,2005,21(10):2069-2074. 被引量:92
  • 3戚凤春,汪春义,张雪梅,王亚军,李晓波,贾媛,赵大鹏,盛军.两种细胞培养流感病毒的滴度比较[J].中国生物制品学杂志,2006,19(3):291-292. 被引量:23
  • 4赵宝洪,高洪,屈长林,陈超.自由基检测方法[J].动物医学进展,2007,28(7):107-110. 被引量:18
  • 5Robertson JS, Cook P, Attwell AM, et al. Replicative advantage in tissue culture of egg-adapted influenza virus over tissue-culture derived virus: implications for vaccine manufacture[J]. Vaccine, 1995, 13: 1583-8.
  • 6Sehotsaert M, De Filette M, Fiefs W, et al. Universal M2 ectodomain based influenza A vaccines: preclinica| and clinical de velopments[J]. Expert Rev Vaccines, 2009, 8(4): 499- 508.
  • 7Katz JM, Wang M, Webster RG, et al. Direct sequencing of the HA gene of influenza (H3N2) virus in original clinical samples re veals sequence identity with mammalian cell grown virus[J]. J Virol, 1990, 64: 1808- 11.
  • 8Robertson JS, Bootman JS, Nieolson C, et al. The hemagglutinin of influenza B virus present in clinical material is a single species i dentical to that of mammalian cell grown virus[J]. Virology, 1990,179: 35-40.
  • 9Merten OW, Manuguerra JC, Hannoun C, et al. Production ot influenza virus in serum free mammalian cell cultures[J]. Dev Bi ol Stand, 1999, 98:23- 37.
  • 10Kistner O, Barrett PN, Mundt W, et al. Development of a mare malian cell (Vero) derived candidate influenza virus vaccine[J]. Vaccine , 1998. 16:960- 8.

共引文献57

同被引文献25

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部